Drug Price Trends for HM MUCUS RELIEF ER

Average Pharmacy Cost for HM MUCUS RELIEF ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
HM MUCUS RELIEF ER 1,200 MG TB	62011-0378-01	0.47744	EACH	2024-07-17
HM MUCUS RELIEF ER 600 MG TAB	62011-0377-01	0.34840	EACH	2024-07-17
HM MUCUS RELIEF ER 600 MG TAB	62011-0382-01	0.34840	EACH	2024-07-17
HM MUCUS RELIEF ER 600 MG TAB	62011-0377-01	0.35001	EACH	2024-06-19
HM MUCUS RELIEF ER 1,200 MG TB	62011-0378-01	0.46875	EACH	2024-06-19
HM MUCUS RELIEF ER 600 MG TAB	62011-0382-01	0.35001	EACH	2024-06-19
HM MUCUS RELIEF ER 600 MG TAB	62011-0382-01	0.32068	EACH	2024-05-22

Market Analysis and Price Projections for HM MUCUS RELIEF ER

Introduction to Guaifenesin

HM MUCUS RELIEF ER, like other guaifenesin-based medications, utilizes guaifenesin, an ether of glycerin and guaiacol, as its active ingredient. Guaifenesin is widely recognized for its expectorant properties, helping to clear mucus and phlegm from the airways, thereby easing breathing[1][4].

Global Guaifenesin Market Overview

The global guaifenesin market, which includes products like HM MUCUS RELIEF ER, is projected to reach USD 95 million by 2027. This growth is anticipated at a Compound Annual Growth Rate (CAGR) of approximately 3.1% from 2022 to 2027[1][4].

Market Segmentation

By Application

The cough treatment drug segment is the fastest-growing within the guaifenesin market, expected to grow at a CAGR of around 3.7% during the forecast period. Guaifenesin's application in treating cough, bronchitis, and chest congestion drives this segment's growth[1][4].

By End-Use Industry

The multispecialty hospital segment held the largest market share in 2021, with over 57% of the global guaifenesin market. This is due to the extensive use of guaifenesin in hospitals for treating various respiratory conditions[1][4].

By Geography

North America is expected to dominate the market, driven by the high prevalence of respiratory diseases, the presence of key players, and rising R&D expenditure. Other significant regions include Europe, Asia-Pacific, and South America[3][4].

Price Projections and Market Dynamics

Demand Drivers

• Increasing Applications in Cough Treatment: The growing use of guaifenesin in cough treatment drugs, especially in hospitals and clinics, is a significant driver. For instance, the Indian pharmaceutical sector is expected to reach USD 65 billion by 2024 and around USD 120-130 billion by 2030, boosting demand for guaifenesin[1][4].
• Consumer Interest in Oral Medications: Increasing consumer preference for oral medications, including expectorants, contributes to the demand. China, with its high incidence of respiratory diseases, is a key market[1][3].

Price Trends

The prices of guaifenesin-based drugs like HM MUCUS RELIEF ER can be influenced by several factors:

• Raw Material Costs: Fluctuations in the cost of glycerin and guaiacol can impact the final product price.
• Regulatory Environment: Changes in regulatory standards related to pharmaceutical manufacturing and safety can affect production costs and subsequently prices.
• Market Competition: The presence of substitutes and the overall competitive landscape in the expectorant drugs market can influence pricing strategies[1].

Regional Market Analysis

North America

North America is expected to dominate the market due to the high prevalence of respiratory diseases, the presence of key players, and rising R&D expenditure. For example, according to the CDC, 4.6% of adults in the U.S. reported being diagnosed with COPD, emphysema, or chronic bronchitis in 2022, driving the demand for expectorant drugs like guaifenesin[3].

Asia-Pacific

The Asia-Pacific region, particularly countries like India and China, is also seeing significant growth. The Indian pharmaceutical sector's expected growth to USD 65 billion by 2024 and around USD 120-130 billion by 2030 will further boost the demand for guaifenesin-based products[1][4].

Challenges and Opportunities

Availability of Substitutes

The global guaifenesin market faces challenges from the availability of substitute expectorants, which can impact market share and pricing. However, innovations in drug delivery and processing can enhance the efficacy and appeal of guaifenesin-based products, potentially leading to higher demand and stable or increasing prices[1][4].

Technological Advancements

Advancements in drug delivery and processing can enhance the efficacy and appeal of guaifenesin-based products. For instance, FDA approvals for OTC guaifenesin extended-release tablets, such as those received by Marksans Pharma in August 2023, can increase market accessibility and consumer preference[3].

Pricing of HM MUCUS RELIEF ER

Current Prices

The prices for HM MUCUS RELIEF ER can vary based on the dosage and formulation. For example:

• 600 MG TAB: Prices range from approximately $0.345 to $0.399 per unit, depending on the date and supplier[1].
• 1200 MG TB: Prices range from approximately $0.472 to $0.476 per unit[1].

Comparative Pricing

Other guaifenesin-based products, like Mucus Relief DM, offer similar pricing structures:

• Mucus Relief DM (30 mg-600 mg) oral tablet, extended release: Around $13 for a supply of 20 tablets[2].

Patient Assistance and Copay Programs

While specific patient assistance programs for HM MUCUS RELIEF ER may not be available, general discount cards and copay programs can help reduce the cost of these medications. For example, the Drugs.com Discount Card can save up to 80% or more off the cost of prescription medicines and over-the-counter drugs[2][5].

Key Takeaways

• Market Growth: The global guaifenesin market is projected to reach USD 95 million by 2027, growing at a CAGR of 3.1% from 2022 to 2027.
• Fastest-Growing Segment: The cough treatment drug segment is the fastest-growing, expected to grow at a CAGR of around 3.7% during the forecast period.
• Dominant Market Segment: The multispecialty hospital segment held the largest market share in 2021.
• Regional Dominance: North America is expected to dominate the market due to high prevalence of respiratory diseases and rising R&D expenditure.
• Price Influencers: Raw material costs, regulatory environment, and market competition influence the prices of guaifenesin-based drugs.

FAQs

1. What is the projected market size for the global guaifenesin market by 2027? The global guaifenesin market is projected to reach USD 95 million by 2027[1][4].

2. Which segment is the fastest-growing in the guaifenesin market? The cough treatment drug segment is the fastest-growing, expected to grow at a CAGR of around 3.7% during the forecast period[1][4].

3. What is the significance of the multispecialty hospital segment in the guaifenesin market? The multispecialty hospital segment held the largest market share in 2021, with over 57% of the global guaifenesin market[1][4].

4. How does the broader expectorant drugs market impact guaifenesin-based products? The expectorant drugs market, valued at USD 17,648.2 million in 2024 and projected to reach USD 38,455.4 million by 2034, drives demand for guaifenesin-based products like HM MUCUS RELIEF ER[1][3].

5. What are the key drivers of the guaifenesin market? Key drivers include growing applications in cough treatment drugs, increasing consumer interest in oral medications, and advancements in hospital infrastructure and technology[1][3][4].

Cited Sources

1. DrugPatentWatch: Market Analysis and Financial Projection for Guaifenesin-Based Drugs.
2. Drugs.com: Mucus Relief DM Prices, Coupons, Copay Cards & Patient Assistance.
3. Mordor Intelligence: Expectorant Drugs Market Size & Share Analysis.
4. IndustryARC: Guaifenesin Market Size Report, 2022-2027.
5. Drugs.com: Mucus Relief Prices, Coupons, Copay Cards & Patient Assistance.